Royal Bank of Canada
ABVC icon

Royal Bank of Canada’s ABVC BioPharma ABVC Stock Holding History

Royal Bank of Canada’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+17
New +$28 ﹤0.01% 7039
2024
Q3 		– Sell
-37
Closed – – 6782
2024
Q2 		$0 Hold
37
– – ﹤0.01% 6972
2024
Q1 		$0 Hold
37
– – ﹤0.01% 6941
2023
Q4 		$0 Hold
37
– – ﹤0.01% 7050
2023
Q3 		$0 Sell
37
-1
-3% -$2 ﹤0.01% 7020
2023
Q2 		$0 Buy
+38
New +$253 ﹤0.01% 7192
2022
Q4 		– Sell
-24
Closed – – 7162
2022
Q3 		$0 Buy
+24
New +$202 ﹤0.01% 7389

Other funds holding ABVC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Royal Bank of Canada's ABVC Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in ABVC BioPharma (ABVC) in Q1 2026: 17 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7039 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in ABVC as recently as Q2 2024.

Royal Bank of Canada first reported a position in ABVC in Q3 2022 and has held it in 7 quarters since. 13 funds tracked by Wall St. Rank hold ABVC as of Q1 2026.

  • Royal Bank of Canada held 17 shares of ABVC BioPharma worth $0 as of Q1 2026.
  • ABVC BioPharma was a new Royal Bank of Canada position in Q1 2026.
  • ABVC BioPharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7039 holding.
  • Royal Bank of Canada first reported a position in ABVC BioPharma in Q3 2022 and has held it in 7 quarters since.
  • 13 funds tracked by Wall St. Rank held ABVC BioPharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.